Autifony Therapeutics

Autifony Therapeutics is a biotech company in Stevenage, United Kingdom, founded in 2011. It has raised $37.0M across 4 rounds, most recently an $11.2M Extension Round in July 2015.

Dedicated to developing new drugs to treat rare CNS disorders using pioneering science

Headquarters
Stevenage
Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$37.0M
Last Round
$11.2M Extension RoundJul 2015
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 6 investors for this company. The full record is or through the API.

About

Autifony Therapeutics is a clinical-stage biotechnology company headquartered at Stevenage Bioscience Catalyst in the UK, founded in 2011. The company is dedicated to developing new medicines for rare genetic central nervous system (CNS) disorders by deploying its pioneering ion channel drug discovery platform. Autifony focuses on conditions including Fragile X Syndrome, advancing a neuroscience pipeline through strategic partnerships and collaborations with leading research institutions, and has been recognized as one of the UK's fastest-growing private biotech companies.

Summary

It lists 11–50 employees. It has raised $37.0M in total across 4 rounds, most recently a $11.2M Extension Round in Jul 2015. Investors include SV Life Sciences, Innovate UK and Imperial Innovations.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundExtension RoundJul 2015
$11.2M

Sign up to see all 4 events

Funding: Seed through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Autifony Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/autifony-therapeutics"><img src="https://indexed.vc/api/badge/company/autifony-therapeutics" alt="Autifony Therapeutics on Indexed.vc" width="260" height="76" /></a>